Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
OSR Holdings, Inc. incurred loan of $50,000 with Bellevue Global Life Sciences Investors LLC at not interest bearing maturing December 31, 2024 or the date on which the Company consummates an initial business combination.
- Instrument
- loan
- Principal
- $50,000
- Counterparty
- Bellevue Global Life Sciences Investors LLC
- Rate
- not interest bearing
- Maturity
- December 31, 2024 or the date on which the Company consummates an initial business combination
- Event
- incurrence
Exact text from the filing
On April 17, 2024, Bellevue Life Sciences Acquisition Corp. (the “ Company ”) issued an unsecured promissory note (the “ Promissory Note ”) in the principal amount of $50,000 to Bellevue Global Life Sciences Investors LLC (“ BGLSI ”), the sponsor of the Company.
View on SEC.gov
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.9
OSR Holdings, Inc. received a nasdaq extension granted notice regarding shareholders (rules 5550(a)(3)).
- Exchange
- nasdaq
- Notice
- extension granted
- Deficiency
- shareholders
- Rules
- 5550(a)(3)
Exact text from the filing
April 17, 2024, the Company received a written notice from Nasdaq indicating that the staff of Nasdaq (the “ Staff ”) has determined, based on its review of the Company’s compliance plan, to grant the Company an extension of time to regain compliance with the Minimum Public Holders Requirement. The terms of the extension are as follows: on or before August 13, 2024, the Company must file with Nasdaq documentation from its transfer agent, or independent source, that demonstrates that its common stock has a minimum of 300 public holders. In the event the Company does not satisfy the terms, the S
View on SEC.gov